Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.

Bengu Tatar Sukran Kose Nadide Colak Ergun Melda Turken Yusuf Özbel Yusuf Yılmaz Sila Akhan

Published in: Revista da Associacao Medica Brasileira (1992) (2020)

In this study, treatment with OBV/PTV/r and DSV with or without RBV resulted in high rates of sustained virologic response in HCV GT1-infected patients with end-stage renal disease (ESRD). SVR was achieved in all patients with few side effects.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
hepatitis c virus
hiv infected
antiretroviral therapy
human immunodeficiency virus
combination therapy